BioLargo Statistics
Total Valuation
BioLargo has a market cap or net worth of 69.90 million. The enterprise value is 66.11 million.
| Market Cap | 69.90M |
| Enterprise Value | 66.11M |
Important Dates
The last earnings date was Friday, March 28, 2025.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BioLargo has 301.30 million shares outstanding. The number of shares has increased by 4.25% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 301.30M |
| Shares Change (YoY) | +4.25% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 6.15% |
| Owned by Institutions (%) | 0.04% |
| Float | 259.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.93 |
| PB Ratio | 11.54 |
| P/TBV Ratio | 7.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -27.52 |
| EV / Sales | 3.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -14.89 |
Financial Position
The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.42.
| Current Ratio | 2.70 |
| Quick Ratio | 2.54 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.58 |
| Interest Coverage | -131.24 |
Financial Efficiency
Return on equity (ROE) is -84.75% and return on invested capital (ROIC) is -37.31%.
| Return on Equity (ROE) | -84.75% |
| Return on Assets (ROA) | -28.92% |
| Return on Invested Capital (ROIC) | -37.31% |
| Return on Capital Employed (ROCE) | -55.07% |
| Revenue Per Employee | 423,310 |
| Profits Per Employee | -57,190 |
| Employee Count | 44 |
| Asset Turnover | 1.90 |
| Inventory Turnover | 41.10 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.14% in the last 52 weeks. The beta is -0.02, so BioLargo's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -30.14% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 0.24 |
| Relative Strength Index (RSI) | 36.84 |
| Average Volume (20 Days) | 184,925 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.45 |
Income Statement
In the last 12 months, BioLargo had revenue of 17.78 million and -2.40 million in losses. Loss per share was -0.01.
| Revenue | 17.78M |
| Gross Profit | 7.85M |
| Operating Income | -4.33M |
| Pretax Income | -4.35M |
| Net Income | -2.40M |
| EBITDA | -4.18M |
| EBIT | -4.33M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 3.55 million in cash and 2.55 million in debt, giving a net cash position of 994,000 or 0.00 per share.
| Cash & Cash Equivalents | 3.55M |
| Total Debt | 2.55M |
| Net Cash | 994,000 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 6.06M |
| Book Value Per Share | 0.03 |
| Working Capital | 4.49M |
Cash Flow
In the last 12 months, operating cash flow was -3.21 million and capital expenditures -1.24 million, giving a free cash flow of -4.44 million.
| Operating Cash Flow | -3.21M |
| Capital Expenditures | -1.24M |
| Free Cash Flow | -4.44M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 44.17%, with operating and profit margins of -24.36% and -13.51%.
| Gross Margin | 44.17% |
| Operating Margin | -24.36% |
| Pretax Margin | -24.45% |
| Profit Margin | -13.51% |
| EBITDA Margin | -23.49% |
| EBIT Margin | -24.36% |
| FCF Margin | n/a |
Dividends & Yields
BioLargo does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.25% |
| Shareholder Yield | -4.25% |
| Earnings Yield | -3.44% |
| FCF Yield | -6.35% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioLargo has an Altman Z-Score of -8.65. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.65 |
| Piotroski F-Score | n/a |